- Home
- ASM vs DRTS Comparison
ASM vs DRTS Comparison
Compare ASM & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASM
- DRTS
- Stock Information
- Founded
- ASM 1968
- DRTS 2015
- Country
- ASM Canada
- DRTS Israel
- Employees
- ASM N/A
- DRTS N/A
- Industry
- ASM Metal Mining
- DRTS Medical/Dental Instruments
- Sector
- ASM Basic Materials
- DRTS Health Care
- Exchange
- ASM Nasdaq
- DRTS Nasdaq
- Market Cap
- ASM 205.8M
- DRTS 211.7M
- IPO Year
- ASM N/A
- DRTS N/A
- Fundamental
- Price
- ASM $2.01
- DRTS $2.57
- Analyst Decision
- ASM Strong Buy
- DRTS Strong Buy
- Analyst Count
- ASM 2
- DRTS 2
- Target Price
- ASM $2.00
- DRTS $8.00
- AVG Volume (30 Days)
- ASM 3.6M
- DRTS 28.0K
- Earning Date
- ASM 05-13-2025
- DRTS 05-19-2025
- Dividend Yield
- ASM N/A
- DRTS N/A
- EPS Growth
- ASM 1287.60
- DRTS N/A
- EPS
- ASM 0.06
- DRTS N/A
- Revenue
- ASM $66,178,000.00
- DRTS N/A
- Revenue This Year
- ASM $24.16
- DRTS N/A
- Revenue Next Year
- ASM $21.17
- DRTS N/A
- P/E Ratio
- ASM $35.01
- DRTS N/A
- Revenue Growth
- ASM 50.78
- DRTS N/A
- 52 Week Low
- ASM $0.68
- DRTS $1.75
- 52 Week High
- ASM $2.04
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- ASM 62.41
- DRTS 46.76
- Support Level
- ASM $1.37
- DRTS $2.52
- Resistance Level
- ASM $2.10
- DRTS $2.61
- Average True Range (ATR)
- ASM 0.15
- DRTS 0.11
- MACD
- ASM 0.03
- DRTS 0.02
- Stochastic Oscillator
- ASM 87.67
- DRTS 87.10
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.